VeriSIM Life logo

VeriSIM Life

In-silico disease specific models for drug development company

2

Funding Rounds

$20.2m

Money raised

Overview

In-silico disease specific models for drug development company

Funding series

Funding Series Analysis

The company VeriSIM Life has raised a total of $15m in funding over 2 rounds.

Key Insights:

  • VeriSIM Life Series A round, January 2022: $15m
  • VeriSIM Life funding round, August 2019: $5.2m
VeriSIM Life logo
VeriSIM Life Series A round, January 2022 $15m
VeriSIM Life logo
VeriSIM Life funding round, August 2019 $5.2m